Scinovex
article Open AccessTop 1% cited

Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007

Thorax · 2013 · Vol. 68(6) · pp. 551–564
Sarah WaltersCamille MaringeMichel P. ColemanMichael PeakeJohn ButlerNicholas YoungStefan BergströmLouise HannaErik JakobsenKarl KölbeckStein SundstrømGerda EngholmAnna GavinMarianne L. GjerstorffJuanita HatcherTom Børge JohannesenKaren M. LinklaterColleen McGahanJohn StewardElizabeth TraceyDonna TurnerMichael A. RichardsBernard Rachetthe ICBP Module 1 Working Group

Abstract

There are comparability issues when using population-based data but, even given these constraints, this study shows that, while differences in stage at diagnosis explain some of the international variation in overall lung cancer survival, wide disparities in stage-specific survival exist, suggesting that other factors are also important such as differences in treatment. Stage should be included in international cancer survival studies and the comparability of population-based data should be improved.

Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsLung Cancer Research StudiesMedicineStage (stratigraphy)Lung cancerPopulationCancerDanishDemographyCancer survivalEnvironmental healthOncology

MeSH terms

AdolescentAdultAgedAged, 80 and overAustraliaCanadaDenmarkFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingNorwayPopulation Surveillance

Funding

  • Cancer Research UK
  • Public Health Agency
Citations
565
FWCI
20.85
field-weighted impact
References
33
Percentile
100%
vs. same field & year
Citations per year
References
TNM: CLASSIFICATION OF MALIGNANT TUMOURS
The Medical Journal of Australia · 1969 · 1,396 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.